Serina Therapeutics reported net income of -$6.36M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||
| Revenue | 0.04M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.03M | 0.01M | 0.03M | 3.09M | 0.01M | 0.05M | 0.01M | -0.01M | 0.13M | |||||||||||||||||||
| Cost of RevenueCost of Rev | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.00M | 0.00M | 0.01M | 0.03M | 0.00M | |||||||||||||||||||||||
| Gross Profit | 0.02M | 0.02M | 0.03M | 0.00M | 0.01M | 0.00M | 0.01M | 0.01M | 0.00M | 0.03M | 0.06M | |||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.48M | 0.28M | 0.38M | 0.40M | 0.26M | 0.16M | 0.21M | 0.40M | 0.48M | 0.60M | 0.91M | 1.11M | 1.59M | 2.42M | 2.37M | 2.95M | 3.15M | 3.65M | 3.40M | 3.82M | ||||||||||||||
| Selling, General & AdministrativeSG&A | 1.75M | 1.42M | 1.52M | 1.66M | 1.34M | 1.39M | 1.58M | 0.59M | 0.47M | 0.89M | 1.94M | 1.22M | 2.32M | 2.91M | 3.17M | 2.91M | 2.54M | 2.74M | 2.81M | 2.97M | ||||||||||||||
| Other Operating ExpensesOther Opex | ||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 2.23M | 1.70M | 1.89M | 2.06M | 1.60M | 1.55M | 1.79M | 0.99M | 0.95M | 1.49M | 2.85M | 2.33M | 3.92M | 5.33M | 5.54M | 5.86M | 5.70M | 6.39M | 6.21M | 6.78M | ||||||||||||||
| Operating IncomeOp. Inc | -2.21M | -1.67M | -1.87M | -2.05M | -1.59M | -1.55M | -1.78M | -0.96M | -0.94M | -1.46M | 0.24M | -2.32M | -3.87M | -5.31M | -5.55M | -5.86M | -5.57M | -6.39M | -6.21M | -6.78M | ||||||||||||||
| EBIT | -2.21M | -1.67M | -1.87M | -2.05M | -1.59M | -1.55M | -1.78M | -0.96M | -0.94M | -1.46M | 0.24M | -2.32M | -3.87M | -5.31M | -5.55M | -5.86M | -5.57M | -6.39M | -6.21M | -6.78M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.28M | 0.29M | 0.57M | 0.86M | 0.92M | 0.98M | 0.09M | 0.11M | 0.10M | 0.18M | 0.19M | 0.31M | 0.02M | 0.02M | 0.01M | 0.01M | 0.20M | 0.20M | ||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | ||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.27M | -0.28M | -0.29M | -0.57M | -0.86M | |||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.10M | 0.09M | 0.09M | 0.06M | 0.04M | 0.04M | 0.05M | 0.07M | 0.04M | -0.10M | 0.23M | ||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.27M | -0.28M | -0.29M | -0.66M | -1.03M | -0.89M | -0.98M | 2.62M | 1.75M | 3.21M | 0.81M | -12.69M | 9.04M | 6.70M | 2.80M | 1.04M | -0.90M | 1.80M | 2.89M | 0.43M | ||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | -2.48M | -1.96M | -2.26M | -2.71M | -2.62M | -2.44M | -2.76M | -1.05M | -1.05M | -1.56M | 0.07M | -2.51M | -4.17M | -5.33M | -5.57M | -5.86M | -5.57M | -6.40M | -6.41M | -6.99M | ||||||||||||||
| Tax ProvisionsTaxes | ||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -2.48M | -1.96M | -2.16M | -2.71M | -2.62M | -2.44M | -2.76M | 1.66M | 0.81M | 1.75M | 1.05M | -15.02M | 5.18M | 1.41M | -2.75M | -4.82M | -6.46M | -4.60M | -3.55M | -6.36M | ||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -0.00M | -0.00M | -0.06M | -0.01M | -0.01M | -0.03M | -0.03M | -0.01M | -0.01M | -0.01M | -0.01M | |||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.48M | -1.96M | -2.26M | -2.71M | -2.62M | -2.44M | -2.76M | -1.05M | -1.05M | -1.56M | 0.07M | -2.51M | -4.17M | -5.33M | -5.57M | -5.86M | -5.57M | -6.40M | -6.41M | -6.99M | ||||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | ||||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -2.48M | -1.96M | -2.26M | -2.71M | -2.62M | -2.44M | -2.76M | -1.05M | -1.05M | -1.56M | 0.07M | -2.51M | -4.17M | -5.33M | -5.57M | -5.86M | -5.57M | -6.40M | -6.41M | -6.99M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -2.48M | -1.96M | -2.26M | -2.71M | -2.62M | -2.44M | -2.76M | -1.05M | -1.05M | -1.56M | 0.07M | -2.51M | -4.17M | -5.33M | -5.57M | -5.86M | -5.57M | -6.40M | -6.41M | -6.99M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | -2.48M | -1.96M | -2.26M | -2.71M | -2.62M | -2.44M | -2.76M | -1.05M | -1.05M | -1.56M | 0.07M | -2.51M | -4.17M | -5.33M | -5.57M | -5.86M | -6.57M | -6.40M | -6.41M | -8.93M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.07 | -0.05 | -0.06 | -0.07 | -0.07 | -0.06 | -0.07 | -0.03 | -0.03 | -0.04 | 0.06 | -0.90 | -0.49 | -0.60 | -0.76 | -0.60 | -0.66 | -0.62 | -0.63 | -0.55 | ||||||||||||||
| EPS (Diluted) | -0.07 | -0.05 | -0.06 | -0.07 | -0.07 | -0.06 | -2.56 | -0.12 | -0.03 | -0.04 | 0.06 | -0.90 | -0.41 | -0.50 | -0.76 | -0.60 | -0.66 | -0.62 | -0.63 | -0.55 | ||||||||||||||
| Shares Outstanding | 37.94M | 37.94M | 37.89M | 37.94M | 37.94M | 37.95M | 37.95M | 37.95M | 37.95M | 37.95M | 1.08M | 2.79M | 8.51M | 8.85M | 7.36M | 9.76M | 10.00M | 10.34M | 10.19M | 16.39M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 37.73M | 37.73M | 37.73M | 37.94M | 37.94M | 37.95M | 1.08M | 8.57M | 37.95M | 37.95M | 1.08M | 2.79M | 10.16M | 10.75M | 7.36M | 9.76M | 10.00M | 10.34M | 10.19M | 16.39M | ||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 37.94M | 37.94M | 37.94M | 37.94M | 37.95M | 37.95M | 37.95M | 37.95M | 37.95M | 37.95M | 1.08M | 2.79M | 8.79M | 8.89M | 7.36M | 9.93M | 10.14M | 10.54M | 10.77M | 16.39M | ||||||||||||||
| EBITDA | -2.21M | -1.67M | -1.87M | -2.05M | -1.59M | -1.55M | -1.78M | -0.96M | -0.94M | -1.46M | 0.24M | -2.32M | -3.87M | -5.31M | -5.55M | -5.86M | -5.57M | -6.39M | -6.21M | -6.78M | ||||||||||||||
| Interest ExpensesInt Expense | 0.28M | 0.29M | 0.57M | 0.86M | 0.92M | 0.98M | 0.09M | 0.11M | 0.10M | 0.18M | 0.19M | 0.31M | 0.02M | 0.02M | 0.01M | 0.01M | 0.20M | 0.20M | ||||||||||||||||
| Tax Rate |